• 1
    Zimmerman C,Brduscha-Riem K,Blaser C, Zinkernagel RM, Pircher H. Visualization, characterization, and turnover of CD8+ memory T cells in virus-infected hosts. J Exp Med 1996; 183: 13671375.
  • 2
    Hulett HR,Bonner WA,Barrett J, Herzenberg LA. Cell sorting: Automated separation of mammalian cells as a function of intracellular fluorescence. Science 1969; 166: 747749.
  • 3
    Hamann D,Baars PA,Rep MH, Hooibrink B, Kerkhof-Garde SR,Klein MR, van Lier RA. Phenotypic and functional separation of memory and effector human CD8+ T cells. J Exp Med 1997; 186: 14071418.
  • 4
    Sallusto F,Lenig D,Forster R, Lipp M, Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions [see comments]. Nature 1999; 401: 708712.
  • 5
    Appay V,Dunbar PR,Callan M, Klenerman P, Gillespie GM, Papagno L, Ogg GS, King A, Lechner F, Spina CA, Little S, Havlir DV, Richman DD, Gruener N, Pape G, Waters A, Easterbrook P, Salio M, Cerundolo V, McMichael AJ, Rowland-Jones SL. Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections. Nat Med 2002; 8: 379385.
  • 6
    De Rosa SC,Herzenberg LA,Roederer M. 11-color, 13-parameter flow cytometry: Identification of human naive T cells by phenotype, function, and T-cell receptor diversity. Nat Med 2001; 7: 245248.
  • 7
    Baars PA,Ribeiro Do Couto LM,Leusen JH, Hooibrink B, Kuijpers TW, Lens SM, van Lier RA. Cytolytic mechanisms and expression of activation-regulating receptors on effector-type CD8+CD45RA+CD27- human T cells. J Immunol 2000; 165: 19101917.
  • 8
    Pittet MJ,Speiser DE,Valmori D, Cerottini JC,Romero P. Cutting edge: Cytolytic effector function in human circulating CD8+ T cells closely correlates with CD56 surface expression. Jimmunol 2000; 164: 11481152.
  • 9
    Faint JM,Annels NE,Curnow SJ, Shields P, Pilling D, Hislop AD, Wu L, Akbar AN, Buckley CD, Moss PA, Adams DH, Rickinson AB, Salmon M. Memory T cells constitute a subset of the human CD8(+)CD45RA(+) pool with distinct phenotypic and migratory characteristics. J Immunol 2001; 167: 212220.
  • 10
    Speiser DE,Colonna M,Ayyoub M, Cella M, Pittet MJ, Batard P, Valmori D, Guillaume P, Lienard D, Cerottini JC, Romero P. The activatory receptor 2B4 is expressed in vivo by human CD8+ effector alpha beta T cells. J Immunol 2001; 167: 61656170.
  • 11
    McMahon CW,Raulet DH. Expression and function of NK cell receptors in CD8+ T cells. Curr Opin Immunol 2001; 13: 465470.
  • 12
    Christensen JE,Andreasen SO,Christensen JP, Thomsen AR. CD11b expression as a marker to distinguish between recently activated effector CD8(+) T cells and memory cells. Int Immunol 2001; 13: 593600.
  • 13
    Wills MR,Okecha G,Weekes MP, Gandhi MK, Sissons PJ, Carmichael AJ. Identification of naive or antigen-experienced human CD8(+) T cells by expression of costimulation and chemokine receptors: Analysis of the human cytomegalovirus-specific CD8(+) T cell response. J Immunol 2002; 168: 54555464.
  • 14
    Tomiyama H,Matsuda T,Takiguchi M. Differentiation of human CD8(+) T cells from a memory to memory/effector phenotype. J Immunol 2002; 168: 55385550.
  • 15
    Fukada K,Sobao Y,Tomiyama H, Oka S, Takiguchi M. Functional expression of the chemokine receptor CCR5 on virus epitope-specific memory and effector CD8+ T cells. J Immunol 2002; 168: 22252232.
  • 16
    Voehringer D,Koschella M,Pircher H. Lack of proliferative capacity of human effector and memory T cells expressing killer cell lectinlike receptor G1 (KLRG1). Blood 2002; 100: 36983702.
  • 17
    Combadiere B,Faure S,Autran B, Debre P, Combadiere C. The chemokine receptor CX3CR1 controls homing and anti-viral potencies of CD8 effector-memory T lymphocytes in HIV-infected patients. AIDS 2003; 17: 12791290.
  • 18
    Brenchley JM,Karandikar NJ,Betts MR, Ambrozak DR, Hill BJ, Crotty LE, Casazza JP, Kuruppu J, Migueles SA, Connors M, Roederer M, Douek DC, Koup RA. Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cells. Blood 2003; 101: 27112720.
  • 19
    Rufer N,Zippelius A,Batard P, Pittet MJ, Kurth I, Corthesy P, Cerottini JC, Leyvraz S, Roosnek E, Nabholz M, Romero P. Ex vivo characterization of human CD8+ T subsets with distinct replicative history and partial effector functions. Blood 2003; 102: 17791787.
  • 20
    Boutboul F,Puthier D,Appay V, Pelle O, Ait-Mohand H, Combadiere B, Carcelain G, Katlama C, Rowland-Jones SL, Debre P, Nguyen C, Autran B. Modulation of interleukin-7 receptor expression characterizes differentiation of CD8 T cells specific for HIV, EBV and CMV. AIDS 2005; 19: 19811986.
  • 21
    van Leeuwen EM,de Bree GJ,Remmerswaal EB, Yong SL, Tesselaar K, ten Berge IJ, van Lier RA. IL-7 receptor alpha chain expression distinguishes functional subsets of virus-specific human CD8+ T cells. Blood 2005; 106: 20912098.
  • 22
    Thimme R,Appay V,Koschella M, Panther E, Roth E, Hislop AD, Rickinson AB, Rowland-Jones SL, Blum HE, Pircher H. Increased expression of the NK cell receptor KLRG1 by virus-specific CD8 T cells during persistent antigen stimulation. J Virol 2005; 79: 1211212116.
  • 23
    Kobayashi N,Kondo T,Takata H, Yokota S, Takiguchi M. Functional and phenotypic analysis of human memory CD8+ T cells expressing CXCR3. J Leukoc Biol 2006; 80: 320329.
  • 24
    Sauce D,Almeida JR,Larsen M, Haro L, Autran B, Freeman GJ, Appay V. PD-1 expression on human CD8 T cells depends on both state of differentiation and activation status. AIDS 2007; 21: 20052013.
  • 25
    Bratke K,Kuepper M,Bade B, Virchow JC Jr., Luttmann W. Differential expression of human granzymes A, B, and K in natural killer cells and during CD8+ T cell differentiation in peripheral blood. Eur J Immunol 2005; 35: 26082616.
  • 26
    Takata H,Takiguchi M. Three memory subsets of human CD8+ T cells differently expressing three cytolytic effector molecules. J Immunol 2006; 177: 43304340.
  • 27
    Sallusto F,Lenig D,Mackay CR, Lanzavecchia A. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J Exp Med 1998; 187: 875883.
  • 28
    Rivino L,Messi M,Jarrossay D, Lanzavecchia A, Sallusto F, Geginat J. Chemokine receptor expression identifies Pre-T helper (Th)1, Pre-Th2, and nonpolarized cells among human CD4+ central memory T cells. J Exp Med 2004; 200: 725735.
  • 29
    Acosta-Rodriguez EV,Rivino L,Geginat J, Jarrossay D, Gattorno M, Lanzavecchia A, Sallusto F, Napolitani G. Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat Immunol 2007; 8: 639646.
  • 30
    Annunziato F,Cosmi L,Santarlasci V, Maggi L, Liotta F, Mazzinghi B, Parente E, Fili L, Ferri S, Frosali F, Giudici F, Romagnani P, Parronchi P, Tonelli F, Maggi E, Romagnani S. Phenotypic and functional features of human Th17 cells. J Exp Med 2007; 204: 18491861.
  • 31
    Duvall MG,Precopio ML,Ambrozak DA, Jaye A, McMichael AJ, Whittle HC, Roederer M, Rowland-Jones SL, Koup RA. Polyfunctional T cell responses are a hallmark of HIV-2 infection. Eur J Immunol 2008; 38: 350363.
  • 32
    Papagno L,Spina CA,Marchant A, Salio M, Rufer N, Little S, Dong T, Chesney G, Waters A, Easterbrook P, Dunbar PR, Shepherd D, Cerundolo V, Emery V, Griffiths P, Conlon C, McMichael AJ, Richman DD, Rowland-Jones SL, Appay V. Immune activation and CD8(+) T-Cell differentiation towards senescence in HIV-1 infection. PLoS Biol 2004; 2: E20.
  • 33
    Romero P,Zippelius A,Kurth I, Pittet MJ, Touvrey C, Iancu EM, Corthesy P, Devevre E, Speiser DE, Rufer N. Four functionally distinct populations of human effector-memory CD8+ T lymphocytes. J Immunol 2007; 178: 41124119.
  • 34
    He XS,Mahmood K,Maecker HT, Holmes TH, Kemble GW, Arvin AM, Greenberg HB. Analysis of the frequencies and of the memory T cell phenotypes of human CD8+ T cells specific for influenza A viruses. J Infect Dis 2003; 187: 10751084.
  • 35
    Tussey LG,Nair US,Bachinsky M, Edwards BH, Bakari J, Grimm K, Joyce J, Vessey R, Steigbigel R, Robertson MN, Shiver JW, Goepfert PA. Antigen burden is major determinant of human immunodeficiency virus-specific CD8+ T cell maturation state: Potential implications for therapeutic immunization. J Infect Dis 2003; 187: 364374.
  • 36
    Amyes E,Hatton C,Montamat-Sicotte D, Gudgeon N, Rickinson AB, McMichael AJ, Callan MF. Characterization of the CD4+ T cell response to Epstein-Barr virus during primary and persistent infection. J Exp Med 2003; 198: 903911.
  • 37
    Yue FY,Kovacs CM,Dimayuga RC, Parks P, Ostrowski MA. HIV-1-specific memory CD4(+) T cells are phenotypically less mature than cytomegalovirus-specific memory CD4(+) T cells. J Immunol 2004; 172: 24762486.
  • 38
    Harari A,Petitpierre S,Vallelian F, Pantaleo G. Skewed representation of functionally distinct populations of virus-specific CD4 T cells in HIV-1-infected subjects with progressive disease: Changes after antiretroviral therapy. Blood 2004; 103: 966972.
  • 39
    Day CL,Seth NP,Lucas M, Appel H, Gauthier L, Lauer GM, Robbins GK, Szczepiorkowski ZM, Casson DR, Chung RT, Bell S, Harcourt G, Walker BD, Klenerman P, Wucherpfennig KW. Ex vivo analysis of human memory CD4 T cells specific for hepatitis C virus using MHC class II tetramers. J Clin Invest 2003; 112: 831842.
  • 40
    Lucas M,Day CL,Wyer JR, Cunliffe SL, Loughry A, McMichael AJ, Klenerman P. Ex vivo phenotype and frequency of influenza virus-specific CD4 memory T cells. J Virol 2004; 78: 72847287.
  • 41
    Alves NL,Hooibrink B,Arosa FA, van Lier RA. IL-15 induces antigen-independent expansion and differentiation of human naive CD8+ T cells in vitro. Blood 2003; 102: 25412546.
  • 42
    Gamadia LE,van Leeuwen EM,Remmerswaal EB, Yong SL, Surachno S, Wertheim-van Dillen PM, Ten Berge IJ, Van Lier RA. The size and phenotype of virus-specific T cell populations is determined by repetitive antigenic stimulation and environmental cytokines. J Immunol 2004; 172: 61076114.
  • 43
    Appay V,Zaunders JJ,Papagno L, Sutton J, Jaramillo A, Waters A, Easterbrook P, Grey P, Smith D, McMichael AJ, Cooper DA, Rowland-Jones SL, Kelleher AD. Characterization of CD4(+) CTLs ex vivo. J Immunol 2002; 168: 59545958.
  • 44
    van Leeuwen EM,Remmerswaal EB,Vossen MT, Rowshani AT, Wertheim-van Dillen PM, van Lier RA, Ten Berge IJ. Emergence of a CD4+CD28- granzyme B+, cytomegalovirus-specific T cell subset after recovery of primary cytomegalovirus infection. J Immunol 2004; 173: 18341841.
  • 45
    Seder RA,Darrah PA,Roederer M. T-cell quality in memory and protection: Implications for vaccine design. Nat Rev Immunol 2008.
  • 46
    Zimmerli SC,Harari A,Cellerai C, Vallelian F, Bart PA, Pantaleo G. HIV-1-specific IFN-gamma/IL-2-secreting CD8 T cells support CD4-independent proliferation of HIV-1-specific CD8 T cells. Proc Natl Acad Sci USA 2005; 102: 72397244.
  • 47
    Betts MR,Nason MC,West SM, De Rosa SC, Migueles SA, Abraham J, Lederman MM, Benito JM, Goepfert PA, Connors M, Roederer M, Koup RA. HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. Blood 2006; 107: 47814789.
  • 48
    Precopio ML,Betts MR,Parrino J, Price DA, Gostick E, Ambrozak DR, Asher TE, Douek DC, Harari A, Pantaleo G, Bailer R, Graham BS, Roederer M, Koup RA. Immunization with vaccinia virus induces polyfunctional and phenotypically distinctive CD8+ T cell responses. J Exp Med 2007; 204: 14051416.
  • 49
    Gamadia LE,Remmerswaal EB,Weel JF, Bemelman F, van Lier RA, Ten Berge IJ. Primary immune responses to human CMV: A critical role for IFN-gamma-producing CD4+ T cells in protection against CMV disease. Blood 2003; 101: 26862692.
  • 50
    Kaech SM,Hemby S,Kersh E, Ahmed R. Molecular and functional profiling of memory CD8 T cell differentiation. Cell 2002; 111: 837851.
  • 51
    Petrovas C,Casazza JP,Brenchley JM, Price DA, Gostick E, Adams WC, Precopio ML, Schacker T, Roederer M, Douek DC, Koup RA. PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infection. J Exp Med 2006; 203: 22812292.
  • 52
    Sallusto F,Kremmer E,Palermo B, Hoy A, Ponath P, Qin S, Forster R, Lipp M, Lanzavecchia A. Switch in chemokine receptor expression upon TCR stimulation reveals novel homing potential for recently activated T cells. Eur J Immunol 1999; 29: 20372045.
  • 53
    van Leeuwen EM,van Buul JD,Remmerswaal EB, Hordijk PL, Ten Berge IJ, van Lier RA. Functional re-expression of CCR7 on CMV-specific CD8+ T cells upon antigenic stimulation. Int Immunol 2005; 17: 713719.
  • 54
    Guarda G,Hons M,Soriano SF, Huang AY, Polley R, Martin-Fontecha A, Stein JV, Germain RN, Lanzavecchia A, Sallusto F. L-selectin-negative CCR7- effector and memory CD8+ T cells enter reactive lymph nodes and kill dendritic cells. Nat Immunol 2007; 8: 743752.
  • 55
    Pitcher CJ,Hagen SI,Walker JM, Lum R, Mitchell BL, Maino VC, Axthelm MK, Picker LJ. Development and homeostasis of T cell memory in rhesus macaque. J Immunol 2002; 168: 2943.
  • 56
    Stemberger C,Huster KM,Koffler M, Anderl F, Schiemann M, Wagner H, Busch DH. A single naive CD8+ T cell precursor can develop into diverse effector and memory subsets. Immunity 2007; 27: 985997.
  • 57
    Arens R,Tesselaar K,Baars PA, van Schijndel GM, Hendriks J, Pals ST, Krimpenfort P, Borst J, van Oers MH, van Lier RA. Constitutive CD27/CD70 interaction induces expansion of effector-type T cells and results in IFNgamma-mediated B cell depletion. Immunity 2001; 15: 801812.
  • 58
    Tesselaar K,Xiao Y,Arens R, van Schijndel GM, Schuurhuis DH, Mebius RE, Borst J, van Lier RA. Expression of the murine CD27 ligand CD70 in vitro and in vivo. J Immunol 2003; 170: 3340.
  • 59
    Fletcher JM,Vukmanovic-Stejic M,Dunne PJ, Birch KE, Cook JE, Jackson SE, Salmon M, Rustin MH, Akbar AN. Cytomegalovirus-specific CD4+ T cells in healthy carriers are continuously driven to replicative exhaustion. J Immunol 2005; 175: 82188225.
  • 60
    Appay V,Bosio A,Lokan S, Wiencek Y, Biervert C, Kusters D, Devevre E, Speiser D, Romero P, Rufer N, Leyvraz S. Sensitive gene expression profiling of human T-cell subsets reveals parallel post-thymic differentiation for CD4+ and CD8+ lineages. J Immunol 2007; 179: 74067414.
  • 61
    Appay V,Nixon DF,Donahoe SM, Gillespie GM, Dong T, King A, Ogg GS, Spiegel HM, Conlon C, Spina CA, Havlir DV, Richman DD, Waters A, Easterbrook P, McMichael AJ, Rowland-Jones SL. HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic function. J Exp Med 2000; 192: 6375.
  • 62
    Champagne P,Ogg GS,King AS, Knabenhans C, Ellefsen K, Nobile M, Appay V, Rizzardi GP, Fleury S, Lipp M, Forster R, Rowland-Jones S, Sekaly RP, McMichael AJ, Pantaleo G. Skewed maturation of memory HIV-specific CD8 T lymphocytes. Nature 2001; 410: 106111.
  • 63
    Almeida JR,Price DA,Papagno L, Arkoub ZA, Sauce D, Bornstein E, Asher TE, Samri A, Schnuriger A, Theodorou I, Costagliola D, Rouzioux C, Agut H, Marcelin AG, Douek D, Autran B, Appay V. Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover. JExp Med 2007; 204: 24732485.
  • 64
    Sacre K,Carcelain G,Cassoux N, Fillet AM, Costagliola D, Vittecoq D, Salmon D, Amoura Z, Katlama C, Autran B. Repertoire, diversity, and differentiation of specific CD8 T cells are associated with immune protection against human cytomegalovirus disease. J Exp Med 2005; 201: 19992010.
  • 65
    Wherry EJ,Teichgraber V,Becker TC, Masopust D, Kaech SM, Antia R, Von Andrian UH, Ahmed R. Lineage relationship and protective immunity of memory CD8 T cell subsets. Nat Immunol 2003; 4: 225234.
  • 66
    Gattinoni L,Klebanoff CA,Palmer DC, Wrzesinski C, Kerstann K, Yu Z, Finkelstein SE, Theoret MR, Rosenberg SA, Restifo NP. Acquisition of full effector function in vitro paradoxically impairs the in vivo antitumor efficacy of adoptively transferred CD8+ T cells. J Clin Invest 2005; 115: 16161626.
  • 67
    Sun Y,Schmitz JE,Buzby AP, Barker BR, Rao SS, Xu L, Yang ZY, Mascola JR, Nabel GJ, Letvin NL. Virus-specific cellular immune correlates of survival in vaccinated monkeys after simian immunodeficiency virus challenge. J Virol 2006; 80: 1095010956.
  • 68
    Berger C,Jensen MC,Lansdorp PM, Gough M, Elliott C, Riddell SR. Adoptive transfer of effector CD8 T cells derived from central memory cells establishes persistent T cell memory in primates. JClin Invest 2008; 118: 294305.
  • 69
    Darrah PA,Patel DT,De Luca PM, Lindsay RW, Davey DF, Flynn BJ, Hoff ST, Andersen P, Reed SG, Morris SL, Roederer M, Seder RA. Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major. Nat Med 2007; 13: 843850.
  • 70
    Hesperger AR,Makedonas G,Betts MR. Flow cytometric detection of perforin upregulation in human CD8 T cells. Cytometry Part A 2008; 73A (in press). DOI: 10.1002/cyto.a.20596 (this issue).
  • 71
    van Baalen C,Gruters RA,Berkhoff EGM,Osterhaus ADME,Rimmelzwaan GF. FATT-CTL assay for detection of antigen-specific cell-mediated cytotoxicity. Cytometry Part A 2008; 73A (in press). DOI: 10.1002/cyto.a.20613 (this issue).
  • 72
    Chattopadhyay P,Melenhorst J,Ladell K,Gostick E,Scheinberg P,Barrett A,Wooldridge L,Roederer M,Sewell A,Price DA. Techniques to improve the direct ex vivo detection of low frequency antigen-specific CD8+ T cells with peptide-major histocompatibility complex class I tetramers. Cytometry Part A 2008; 73A (in press). DOI: 10.1002/cyto.a.20642 (this issue).
  • 73
    Fuhrmann S,Streitz M,Kern F. How flow cytometry is changing the study of TB immunology and clinical diagnosis. Cytometry Part A 2008; 73A (in press). DOI: 10.1002/cyto.a.20614 (this issue).
  • 74
    Cecconi V,Moro M,Del Mare S,Dellabona P,Casorati G. Use of MHC Class II tetramers to investigate CD4+ T cell responses: Problems and solutions. Cytometry Part A 2008; 73A (in press). DOI: 10.1002/cyto.a.20603 (this issue).
  • 75
    Meier S,Stark R,Frentsch M,Thiel A. The influence of different stimulation conditions on the assessment of antigen-induced CD154 expression on CD4+ T cells. Cytometry Part A 2008; 73A (in press). DOI: 10.1002/cyto.a.20640 (this issue).